Author:
Bourke L,Kirkbride P,Hooper R,Rosario A J,Chico T J A,Rosario D J
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. BAUS (2009) MDT (Multi-disciplinary Team) Guidance for Managing Prostate Cancer, 2nd Edition,
http://www.baus.org.uk/OneStopCMS/Core/CrawlerResourceServer.aspx?resource=46DCF307-C35A-49DC-A434-277247665440&mode=link&guid=20cddeffbd274b5cbec7ba0e6f721dcc
(Accessed 01/09/2012)
2. Blankfield RP (2012) Androgen deprivation therapy for prostate cancer and cardiovascular death. JAMA: the journal of the American Medical Association 307 (12): 1252; author reply 1252–1253
3. Bolla M, Van Tienhoven G, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Billiet I, Torecilla JL, Pfeffer R, Cutajar CL, Van der Kwast T, Collette L (2010) External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. Lancet Oncol 11 (11): 1066–1073
4. Bourke L, Chico TJ, Albertsen PC, Hamdy FC, Rosario DJ (2011) Cardiovascular risk in androgen suppression: underappreciated, under-researched and unresolved. Heart 98 (5): 345–348
5. D’Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW (2008) Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. JAMA: the journal of the American Medical Association 299 (3): 289–295
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献